Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,400 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Frontiers in Immunology, 2023Olink proteomics analysis uncovers the landscape of inflammation-related proteins in patients with acute compartment syndrome
Wang T., Yang S., Long Y. et al.
Olink Target 96
European Journal of Cancer, 2023FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response prediction
van Eijck C., Strijk G., Vietsch E. et al.
Olink Explore 3072/384
European Journal of Heart Failure, 2023Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program
Ferreira J., Packer M., Butler J. et al.
PLOS ONE, 2023Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
Siegbahn A., Eriksson N., Assarsson E. et al.
Olink Focus
Journal of Experimental & Clinical Cancer Research, 2023Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
Wimmer K., Sachet M., Ramos C. et al.
Clinical and Translational Medicine, 2023Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis
Meng H., Sengupta A., Ricciotti E. et al.
European Heart Journal, 2023Autoantibodies against the chemokine receptor 3 predict cardiovascular risk
Müller F., Aherrahrou Z., Grasshoff H. et al.
ESC Heart Failure, 2023Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial
Santos‐Ferreira D., Diaz S., Ferreira J. et al.
iScience, 2023TRAIL-dependent apoptosis of peritoneal mesothelial cells by NK cells promotes ovarian cancer invasion
Steitz A., Schröder C., Knuth I. et al.
Journal of the American College of Cardiology, 2023Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease
Mazidi M., Wright N., Yao P. et al.
Journal of the American College of Cardiology, 2023Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure
Ouwerkerk W., Belo Pereira J., Maasland T. et al.
Brain Communications, 2023Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosis
Zhu W., Chen C., Zhang L. et al.
Communications Biology, 2023Identification of circulating proteins associated with general cognitive function among middle-aged and older adults
Tin A., Fohner A., Yang Q. et al.
Kidney International Reports, 2023Proteome-Wide Changes in Blood Biomarkers During Hemodialysis
Lanktree M., Collister D., Pigyere M. et al.
Cell Reports Medicine, 2023Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese
Jia X., Song E., Liu Y. et al.
Clinical and Translational Allergy, 2023Inflammatory related plasma proteins involved in acute preschool wheeze
Holmdahl I., Chakraborty S., Hoyer A. et al.
Molecular Psychiatry, 2023Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse models
Naia L., Shimozawa M., Bereczki E. et al.
Olink Target 96 Mouse
Biomedicine & Pharmacotherapy, 2023Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses
Ruiz-Ponce M., Cuesta-López L., López-Montilla M. et al.
Nature Communications, 2023Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
Åkesson J., Hojjati S., Hellberg S. et al.
Journal of the American Heart Association, 2023Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study
Shah R., Hwang S., Murthy V. et al.
3478 publications
Items per page
2481-2500 of 3478 publications